SR

Seerat Riyaz

Active Director Director DIN 06825011
DIN 06825011 First appointment Aug 2014 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2014
Shareholding value •••• Premium profile

About Seerat Riyaz

Data last updated:

Seerat Riyaz is a Director at Astraazin Pharmaceuticals Private Limited (since 2014). The company operates in Pharma. Astraazin Pharmaceuticals Private Limited reported revenue of ₹4.00 Cr (FY 2025).

DIN 06825011
Primary Designation Director
Industry Pharma
First Appointment 08 Aug 2014
Oldest Company Age 12 yrs
Largest company Astraazin Pharmaceuticals Private Limited · ₹4.00 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director08 Aug 20142014₹4.00 Cr (FY 2025)Active

Board colleagues of Seerat Riyaz

NameDINCompanyDesignation
Riyaz Ahmad Wani02508923Astraazin Pharmaceuticals Private LimitedManaging Director

Directorship timeline

Open interactive timeline →
Astraazin Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Seerat Riyaz

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Seerat Riyaz

Seerat Riyaz currently holds 1 directorship: Astraazin Pharmaceuticals Private Limited (Director, since 08 Aug 2014, revenue ₹4.00 Cr (FY 2025)).

Seerat Riyaz was first appointed on 08 Aug 2014 as Director at Astraazin Pharmaceuticals Private Limited.

The current boards of Seerat Riyaz's companies include Riyaz Ahmad Wani (Astraazin Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available